J.P. Morgan Initiates Coverage on Metabolix at Neutral

According to J.P. Morgan, Metabolix MBLX coverage is initiated with a Neutral rating. J.P. Morgan said that it initiates coverage of Metabolix with a Neutral rating and a December 2012 price target of $5.00. “We expect Metabolix to reach positive EPS in 2016. Our Neutral rating in part reflects the postponed profit stream of Metabolix.” Metabolix closed on Friday at $4.33.